Schreiner MediPharm enhances pharmaceutical packaging with innovative security and barrier solutions 

GERMANY – Schreiner MediPharm, the pharmaceutical labels division of Schreiner Group, has introduced a groundbreaking cut-through indicator function for closure seals designed to enhance pharmaceutical packaging security.

This innovation ensures tampering attempts are immediately visible, reinforcing the integrity of the healthcare supply chain. 

Unlike traditional solutions, the cut-through indicator is a modular feature that can be customized for different closure seals, materials, and designs, catering to the unique requirements of pharmaceutical products.

Its single-layer structure allows for a cost-effective and flexible application. 

Distinctive die-cutting contours make any lateral shifts or tampering-related defects clearly noticeable.

Additional features such as raised structures, irregular outer contours, and guilloche graphic elements can be incorporated to enhance security and authentication further. 

Compliant with ISO 21976 and the European Falsified Medicines Directive 2011/62/EU, the indicator meets the highest international security standards. Once the seal is cut, tampering becomes irreversibly visible, deterring unauthorized access to folding box contents.

This innovation addresses the significant health risks and reputational damage posed by counterfeit or tampered drugs. 

Advanced gas barrier function labels for COC syringes 

In parallel, Schreiner MediPharm has launched gas barrier function labels to address the oxygen ingress challenges associated with cyclo-olefin copolymer (COC) syringes.

While prefilled COC syringes offer advantages such as break resistance, reduced weight, and flexibility in design, they have limited gas barrier properties, posing a challenge for oxygen-sensitive biologics and biosimilars. 

To mitigate this, Schreiner MediPharm’s new labels significantly reduce oxygen diffusion, protecting sensitive drugs.

Two variants of Schreiner MediPharm’s gas barrier function labels are available to meet diverse pharmaceutical needs.

The Gas-Protect-Label is designed to maximize coverage of the syringe barrel, providing a robust barrier against oxygen ingress.

This solution is ideal for applications where extensive protection of the barrel surface is critical to maintaining the integrity of oxygen-sensitive medications.

The Syringe-Closure-Wrap takes functionality further by acting as a second-skin wrap that encases the syringe barrel and cap.

This variant offers an additional barrier against gas diffusion and incorporates an integrated first-opening indication for tamper evidence.

The tamper-evident feature ensures that any unauthorized access to the syringe is immediately visible, enhancing security and reliability.

Both label variants have demonstrated their ability to effectively reduce oxygen ingress when tested on SCHOTT TOPPAC 1 ml long COC syringes.

These labels are tailored to individual products and their active pharmaceutical ingredients (APIs), enabling pharmaceutical manufacturers to add a robust oxygen barrier without altering primary packaging or complex processing. 

“Thanks to our functional labels with a barrier function, sensitive APIs in COC syringes can be reliably protected against gas diffusion without requiring major capital expenditures,” said Stefan Wiedemann, Senior Director of Strategic Marketing and Business Development at Schreiner MediPharm.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.